Treatment of High-Risk Hypertensive Patients: Unresolved Issues Revised by Staging the Risk

By Ruilope Luis M.  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 1, 2006-01 ,pp. : 13-19

Adis International

Access to resources Recommend Favorite

Cardiovascular Risk In White-coat and Sustained Hypertensive Patients

By Celis Hilde   Staessen Jan A.   Thijs Lutgarde   Buntinx Frank   De Buyzere Marc   Hond Elly Den   Fagard Robert H.   O'Brien Eoin T.  

Blood Pressure, Vol. 11, Iss. 6, 2002-11 ,pp. : 352-356

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Treatment of Hypertensive Patients with Fixed Combination Perindopril/Indapamide Up to 10/2.5 mg: Results of the FALCO FORTE Programme

By Pella Daniel  

High Blood Pressure & Cardiovascular Prevention, Vol. 18, Iss. 3, 2011-09 ,pp. : 107-113

Adis International

Access to resources Recommend Favorite

Effects of candesartan versus amlodipine on home-measured blood pressure, QT dispersion and left ventricular hypertrophy in high-risk hypertensive patients

By Matsuno Yasunari   Minatoguchi Shinya   Fujiwara Hisayoshi    

Blood Pressure, Vol. 20, Iss. 1, 2011-04 ,pp. : 12-19

Informa Healthcare

Access to resources Recommend Favorite

Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE Trial

By Kjeldsen Sverre E.   Julius Stevo   Brunner Hans   Hansson Lennart   Henis Marc   Ekman Steffan   Laragh John   McInnes Gordon   Smith Beverly   Weber Michael   Zanchetti Alberto  

Blood Pressure, Vol. 10, Iss. 2, 2001-04 ,pp. : 83-91

Informa Healthcare

Access to resources Recommend Favorite